Proteostasis Therapeutics
Why Robinhood?
You can watch PTI and buy or sell other stocks, ETFs, and their options commission-free!About PTI
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb.
PTI Key Statistics
Stock Snapshot
With a market cap of 25.59M, Proteostasis Therapeutics(PTI) trades at $1.89. The stock has a price-to-earnings ratio of -0.50.
During the trading day, Proteostasis Therapeutics(PTI) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Proteostasis Therapeutics(PTI) stock has reached 0, versus its average volume of 15.46K.
The stock's 52-week range extends from a low of $0.18 to a high of $1.15.
The stock's 52-week range extends from a low of $0.18 to a high of $1.15.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.